Skip to content
Tenfell
Awarded contract
Published 10 Aug 2023

CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins

NHS England · London

Key facts

Awarded
13 Jul 2023
Contract starts
31 Aug 2023
Contract ends
31 Aug 2025
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 8 suppliers

SupplierValue
Dr Reddy's Laboratories (UK) Ltd—
Pfizer Ltd—
Aventis Pharma Ltd T/A Sanofi—
Mylan—
LEO Pharma Ltd—
ROVI Biotech Ltd—
Techdow Pharma England Ltd—
Tetris Pharma Ltd—

Description

NHS National Framework for low molecular weight heparin products and fondaparinux Offer reference number: CM/PHR/22/5687 Period of framework: 1 September 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.